Author: Reuters

ZURICH (Reuters) – GlaxoSmithKline is buying Novartis out of their consumer healthcare joint venture for $13 billion, taking full control of products including Sensodyne toothpaste, Panadol headache tablets, muscle gel...

ZURICH (Reuters) – GlaxoSmithKline will buy Novartis’s 36.5 percent stake in their consumer healthcare joint venture for $13.0 billion in cash, the partners said on...

ZURICH (Reuters) – Novartis will sell its 36.5 percent stake in a consumer healthcare joint venture to GSK for $13.0 billion in cash to focus on strategic priorities, the Swiss drugmaker said on...

SYDNEY (Reuters) – Asian share markets sprang higher on Tuesday as reports of behind-the-scenes talks between the United States and China rekindled hopes that a damaging trade war could be averted, in turn sapping life...

SYDNEY (Reuters) – Asian share markets rose sharply on Tuesday as reports of behind-the-scenes talks between the United States and China rekindled hopes a damaging trade war could be averted, in turn sapping the strength...